Capricor Therapeutics
Innovative cell and exosome-based therapeutics for disease treatment and prevention. Learn more
Launch date
Employees
Market cap
€124m
Enterprise valuation
€99m (Public information from Sep 2024)
Share price
$4.99 CAPR
Beverly Hills California (HQ)
Authorizing premium user...